Workflow
FENGZHUSHOU CO.(301382)
icon
Search documents
蜂助手:公司将在定期报告中披露对应时点的股东人数
Zheng Quan Ri Bao Wang· 2026-02-04 12:12
证券日报网讯2月4日,蜂助手(301382)在互动平台回答投资者提问时表示,为保证信息披露的公平 性,公司将在定期报告中披露对应时点的股东人数。 ...
蜂助手:云终端技术有望进一步挖掘各类场景化需求
Zheng Quan Ri Bao· 2026-02-03 11:11
(文章来源:证券日报) 证券日报网讯 2月3日,蜂助手在互动平台回答投资者提问时表示,公司紧跟鸿蒙原生应用的发展节 奏,持续迭代升级云终端核心技术并加大相关研发投入,通过云端算力调度与端云协同技术能力,实现 多设备高效协同,同时依托云端算力赋能,有效提升老旧设备的运行体验,实现旧设备的功能焕新。公 司云终端技术有望进一步挖掘各类场景化需求,为公司带来新的增量市场空间。 ...
蜂助手:公司依托云终端技术与算力运营能力,可提供终端虚拟化等技术解决方案
Zheng Quan Ri Bao· 2026-02-03 11:11
证券日报网讯 2月3日,蜂助手在互动平台回答投资者提问时表示,公司依托云终端技术与算力运营能 力,在运营商提供的网络基础上,凭借端到端的全栈技术构建核心竞争力,可提供终端虚拟化、云 OS、算力资源智慧调度引擎、端云协同引擎、SDK等技术解决方案,充分保障网络数据传输与网络时 延等。公司相关核心技术均有专利布局与技术储备,具体技术指标请以公开信息为准。 (文章来源:证券日报) ...
从卖方到买方市场,医美行业迈入成熟竞争新阶段
Core Insights - The domestic medical beauty industry is undergoing a structural transformation in 2025, shifting from a "seller's market" to a "buyer's market" due to an increase in the supply of upstream products [1] - The approval of 52 new Class III medical device registrations in 2025 indicates a significant change in the supply-demand relationship within the industry [1] - Upstream manufacturers are compelled to adjust their competitive strategies, focusing on technological innovation, product iteration speed, and commercialization capabilities [1][4] Upstream Manufacturers - The competition among upstream manufacturers is intensifying as the medical beauty market continues to expand and diversify, with the industry size surpassing 300 billion yuan [3] - The light medical beauty market is expected to grow at a compound annual growth rate of over 20% in the next five years, becoming the mainstream segment [3] - Hyaluronic acid, botulinum toxin, collagen, and regenerative materials are projected to dominate the injection materials market in 2024, with respective market shares of 36%, 29%, 19%, and 16% [3] Product Supply Expansion - In 2025, 25 new Class III medical device registrations for hyaluronic acid products were approved, alongside approvals for collagen products, youth needles, and new materials like agarose and calcium phosphate [4] - Manufacturers are shifting from a "follow the trend" model to focusing on product innovation and expanding new indications, particularly in women's health-related aesthetics [4][5] Competitive Landscape - The competition is expected to transition from merely obtaining licenses to a focus on core technology, research efficiency, and understanding end-user needs [5] - The relationship between upstream manufacturers and downstream medical beauty institutions is evolving into a mutually beneficial partnership rather than a zero-sum game [6] Downstream Institutions - The approval of 52 new Class III medical device registrations has provided downstream institutions with greater product selection and negotiating power with upstream manufacturers [6] - New Oxygen's introduction of competitively priced products has sparked controversy among upstream manufacturers, highlighting the ongoing price competition in the market [6] Market Dynamics - Public hospitals are increasingly entering the medical beauty sector, with 203 hospitals opening or establishing medical beauty departments in 2025, a 229% increase from the previous year [8] - Major internet platforms like Meituan and Tmall are leveraging their traffic advantages to enhance the medical beauty sector, intensifying market competition [8] - The future of the medical beauty industry is expected to be characterized by a diverse and competitive landscape, where trust and professional credibility are crucial for consumer acceptance [8]
蜂助手:加速推进AI应用一体化全面落地
本报讯 (记者李昱丞)1月28日,合觅科技品牌发布会暨产品发布会在2026年好莱客经销商峰会上顺利 举行。发布会上,合觅科技智能家居产品——智能5GCPE音箱、智能云音箱、语音助手-觅宝等一系列 AI智能家居产品公开亮相,呈现智能家居解决方案。 资料显示,广州合觅科技有限公司由蜂助手股份有限公司(以下简称"蜂助手")、广州好莱客创意家居 股份有限公司、广东好太太科技集团股份有限公司联合投资成立。蜂助手为合资公司提供硬件集成模 组、无线宽带连接、窄带通信技术、自研垂类模型、端云协同、数字权益资源等能力及服务。 蜂助手方面表示,未来凭借公司在AI大模型融合、数字权益、物联网通信整合等领域的核心优势,将 加快落地推出各类AI智能终端,以其为万物互联的关键节点,助力各场景的AI应用落地。 (编辑 郭之宸) 蜂助手相关负责人表示,这是蜂助手全面推进"硬件+云终端+服务+场景"的AI应用一体化的重要举措。 一方面,蜂助手将成熟的无线宽带与Mesh组网能力深度适配家庭场景,叠加TPUNB超窄带通信技术的 低功耗、广覆盖特性,实现家中各类智能终端的自动组网与稳定连接,解决了市场同类产品需用户手动 逐一配对、连接稳定性不足的行 ...
减持2.44亿仍持股8%,海峡创新16倍净利暴增背后,蜂助手算力赛道红利
Xin Lang Cai Jing· 2026-01-29 05:21
1月28日晚间,A股市场迎来两则关联性极强的业绩预告—— 海峡创新 互联网 股份有限公司与参股公司 蜂助手 同步披露2025年度业绩答卷,一场"减持方盈利暴增、被减持方业绩稳增"的罕见双赢格局浮出 水面。记者梳理两家公司公告发现,海峡创新预计2025年归母净利润将达到1亿元至1.5亿元,较上年同 期的568万元暴涨1660.56%至2540.85%;而同期为其业绩"输血"的蜂助手,归母净利润也预计实现6.16% 至30.09%的稳健增长,两份预告既勾勒出企业各自的经营脉络,也折射出资本市场中优质股权布局与 主业聚焦的平衡之道。 海峡创新的业绩暴增,核心 驱动力 并非主营业务的突破,而是精准的股权减持操作。公告明确显示, 公司2025年非经常性损益影响金额约为2亿元至3亿元,这部分收益主要来源于2025年6月至12月期间对 蜂助手股票的减持。据统计,在此期间,海峡创新通过集中竞价与大宗交易相结合的方式,累计减持蜂 助手837万股,占其总股本的2.93%,交易金额达2.44亿元。此次减持后,海峡创新对蜂助手的持股比例 从11.05%降至8.12%,既保留了对核心参股企业的重要话语权,又成功盘活了存量资产。 蜂助手 ...
牛股“砸”了牛股 海峡创新靠减持蜂助手股票迎来2025年度净利润爆发式增长
Mei Ri Jing Ji Xin Wen· 2026-01-28 16:44
1月28日晚间,海峡创新(SZ300300)披露2025年业绩预告,公司预计归母净利润同比增长1660.56%至 2540.85%,实现盈利1亿元至1.5亿元。其中,非经常性损益影响金额约为2亿元~3亿元,主要因为公司 于2025年6月至12月减持牛股蜂助手(SZ301382)部分股票。 去年牛股"砸"了另一只牛股 1月28日晚间,海峡创新披露业绩预告,2025年,公司归属于上市公司股东的净利润预计较上年同期有 所增长,其中非经常性损益影响金额约为2亿元~3亿元。 公司预计扣非后归母净利润亏损9800万元~14500万元,上年同期亏损1.33亿元;预计归属于上市公司 股东的净利润盈利1亿元~1.5亿元,比上年同期增长1660.56%~2540.85%。 海峡创新这一归母净利润增速有些爆炸,主要是因为减持了蜂助手股票。 公司于2025年6月至12月通过减持持有的部分蜂助手股票,进一步整合与优化了资产结构,提升了资产 流动性及使用效率,进而显著增加了公司归属于上市公司股东的净利润。 《每日经济新闻》记者注意到,去年8月,海峡创新曾披露计划减持蜂助手股票的公告。 蜂助手是去年资本市场牛股,公司主要从事数字商品综合运 ...
牛股“砸”了牛股,海峡创新靠减持蜂助手股票迎来2025年度净利润爆发式增长
Mei Ri Jing Ji Xin Wen· 2026-01-28 16:37
Core Viewpoint - The company, Haixia Innovation, expects a significant increase in net profit attributable to shareholders in 2025, primarily due to the reduction of its holdings in the stock of Fengzhushou, which has positively impacted its financial performance [1][2]. Financial Performance - The company forecasts a net profit attributable to shareholders of between 1 billion to 1.5 billion yuan, representing a year-on-year growth of 1660.56% to 2540.85% [1][2]. - Non-recurring gains and losses are estimated to impact the financial results by approximately 200 million to 300 million yuan, mainly due to the partial divestment of Fengzhushou shares [1][2]. Stock Divestment Strategy - The company plans to reduce its holdings in Fengzhushou by up to 8.3746 million shares, accounting for 2.93% of Fengzhushou's total share capital, through various methods including centralized bidding and block trading [2][4]. - The divestment is part of a strategy to optimize asset structure and improve liquidity and efficiency, which has significantly contributed to the expected profit increase [2][4]. Business Focus - Despite the gains from Fengzhushou, the company emphasizes its commitment to its core business, focusing on the development of smart city initiatives and exploring new growth opportunities to enhance overall competitiveness and drive high-quality development [5].
蜂助手(301382) - 301382蜂助手投资者关系管理信息20260128
2026-01-28 15:28
| ☑ | 特定对象调研 | □分析师会议 | | --- | --- | --- | | | □媒体采访 | □业绩说明会 | | 投资者关系活 | □新闻发布会 | □路演活动 | | 动类别 | | | | | □现场参观 | | | ☑ | 其他 投资者通过线上会议方式接入 | | | | 天风证券、博时基金、恒泰证券、湖南源乘私募基金、杭州拾 | | | | 年投资、天弘基金、诺安基金、泰康資產(香港)、上海筌笠 | | | | 资产、睿亿投资、太平基金、承珞(上海)投资、中信证券、 | | | | 南京青云合益投资、招商局仁和人寿保险、北京源乐晟资产、 | | | Ten | Management、国信证券、上海方御投资、Marshall Asset | | | | Wace、泰信基金、上海侏罗纪资产、深圳前海云溪基金、循远 | | | 参与单位名称 | 资产(上海)、浙江臻远投资、中信建投基金、长城财富保险 | | | 及人员姓名 | 资产、杭州明见投资、诺德基金、深圳前海无锋基金、上海非 | | | | 马投资、同泰基金、瑞锐投资(上海)、华泰证券(上海)资 | | | | 产、卷柏科技、中国 ...
蜂助手发预增,预计2025年度归母净利润1.42亿元至1.74亿元,增长6.16%至30.09%
Zhi Tong Cai Jing· 2026-01-28 11:57
蜂助手(301382)(301382.SZ)披露2025年度业绩预告,公司预计归属于上市公司股东的净利润1.42亿元 至1.74亿元,同比增长6.16%至30.09%;扣除非经常性损益后的净利润1.4亿元至1.71亿元,同比增长 6.61%至30.21%。 ...